{"id":"https://openalex.org/W4302014288","doi":"https://doi.org/10.1111/cbdd.14151","title":"Electronic effect\u2010dependent intramolecular non\u2010covalent interactions on the activity of 4,4\u2010dimethylimidazolidin\u20102\u2010one pharmacophore\u2010based androgen receptor antagonists","display_name":"Electronic effect\u2010dependent intramolecular non\u2010covalent interactions on the activity of 4,4\u2010dimethylimidazolidin\u20102\u2010one pharmacophore\u2010based androgen receptor antagonists","publication_year":2022,"publication_date":"2022-10-05","ids":{"openalex":"https://openalex.org/W4302014288","doi":"https://doi.org/10.1111/cbdd.14151","pmid":"https://pubmed.ncbi.nlm.nih.gov/36198102"},"language":"en","primary_location":{"id":"doi:10.1111/cbdd.14151","doi":"https://doi.org/10.1111/cbdd.14151","is_oa":false,"landing_page_url":"https://doi.org/10.1111/cbdd.14151","pdf_url":null,"source":{"id":"https://openalex.org/S123587420","display_name":"Chemical Biology & Drug Design","issn_l":"1747-0277","issn":["1747-0277","1747-0285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chemical Biology & Drug Design","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080508837","display_name":"Muralikrishna Yaragani","orcid":"https://orcid.org/0000-0002-0356-7868","observed_orcids":["https://orcid.org/0000-0002-0356-7868"]},"institutions":[{"id":"https://openalex.org/I875944469","display_name":"Koneru Lakshmaiah Education Foundation","ror":"https://ror.org/02k949197","country_code":"IN","type":"education","lineage":["https://openalex.org/I875944469"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Muralikrishna Yaragani","raw_affiliation_strings":["Department of Chemistry, Koneru Lakshmaiah Education Foundation, Guntur, Andhra Pradesh, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Koneru Lakshmaiah Education Foundation, Guntur, Andhra Pradesh, India","institution_ids":["https://openalex.org/I875944469"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046428703","display_name":"Prasad Yadlapalli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091129","display_name":"GVK (India)","ror":"https://ror.org/00eqbn006","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210091129"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Prasad Yadlapalli","raw_affiliation_strings":["GVK Biosciences Pvt. Ltd, Hyderabad, Telangana, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GVK Biosciences Pvt. Ltd, Hyderabad, Telangana, India","institution_ids":["https://openalex.org/I4210091129"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012485378","display_name":"Sriram Srinivasa Raghavan","orcid":"https://orcid.org/0000-0003-3781-3921","observed_orcids":["https://orcid.org/0000-0003-3781-3921"]},"institutions":[{"id":"https://openalex.org/I215927","display_name":"University of Madras","ror":"https://ror.org/04jmt9361","country_code":"IN","type":"education","lineage":["https://openalex.org/I215927"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Sriram Raghavan","raw_affiliation_strings":["CAS in Crystallography and Biophysics, University of Madras, Guindy Campus, Chennai, Tamil Nadu, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CAS in Crystallography and Biophysics, University of Madras, Guindy Campus, Chennai, Tamil Nadu, India","institution_ids":["https://openalex.org/I215927"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010146342","display_name":"Thota Giridhar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thota Giridhar","raw_affiliation_strings":["Sigma-Aldrich Chemicals Pvt. Ltd, Bangalure, Karnataka, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sigma-Aldrich Chemicals Pvt. Ltd, Bangalure, Karnataka, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000377332","display_name":"Venkata Basaveswara Rao Mandava","orcid":"https://orcid.org/0000-0002-3822-7070","observed_orcids":["https://orcid.org/0000-0002-3822-7070"]},"institutions":[{"id":"https://openalex.org/I221092938","display_name":"Krishna University","ror":"https://ror.org/04yhntq62","country_code":"IN","type":"education","lineage":["https://openalex.org/I221092938"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Venkata Basaveswara Rao Mandava","raw_affiliation_strings":["Department of Chemistry, Krishna University, Krishna, Andhra Pradesh, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Krishna University, Krishna, Andhra Pradesh, India","institution_ids":["https://openalex.org/I221092938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102737772","display_name":"Ravindra Vikram Singh","orcid":"https://orcid.org/0000-0002-1984-8461","observed_orcids":["https://orcid.org/0000-0002-1984-8461"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ravindra Vikram Singh","raw_affiliation_strings":["Sigma-Aldrich Chemicals Pvt. Ltd, Bangalure, Karnataka, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sigma-Aldrich Chemicals Pvt. Ltd, Bangalure, Karnataka, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074328732","display_name":"Rajasekhara Prasad Kottapalli","orcid":"https://orcid.org/0000-0002-8087-954X","observed_orcids":["https://orcid.org/0000-0002-8087-954X"]},"institutions":[{"id":"https://openalex.org/I875944469","display_name":"Koneru Lakshmaiah Education Foundation","ror":"https://ror.org/02k949197","country_code":"IN","type":"education","lineage":["https://openalex.org/I875944469"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Rajasekhara Prasad Kottapalli","raw_affiliation_strings":["Department of Chemistry, Koneru Lakshmaiah Education Foundation, Guntur, Andhra Pradesh, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Koneru Lakshmaiah Education Foundation, Guntur, Andhra Pradesh, India","institution_ids":["https://openalex.org/I875944469"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5028682139","display_name":"C. Saravanan","orcid":"https://orcid.org/0000-0003-4595-6551","observed_orcids":["https://orcid.org/0000-0003-4595-6551"]},"institutions":[{"id":"https://openalex.org/I4405257457","display_name":"Sona College of Technology","ror":"https://ror.org/059sbnj83","country_code":"IN","type":"education","lineage":["https://openalex.org/I4405257457"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Saravanan Chinnusamy","raw_affiliation_strings":["Center for Advanced Organic Materials (Sona-AROMA), Department of Chemistry, Sona College of Technology, Salem, Tamil Nadu, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Advanced Organic Materials (Sona-AROMA), Department of Chemistry, Sona College of Technology, Salem, Tamil Nadu, India","institution_ids":["https://openalex.org/I4405257457"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5000377332","https://openalex.org/A5028682139"],"corresponding_institution_ids":["https://openalex.org/I221092938","https://openalex.org/I4405257457"],"apc_list":{"value":3450,"currency":"USD","value_usd":3450},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":95},"biblio":{"volume":"101","issue":"3","first_page":"614","last_page":"625"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.6514000296592712,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.6514000296592712,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.21369999647140503,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.09629999846220016,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/androgen-receptor-antagonists","display_name":"androgen receptor antagonists","score":0.9980000257492065},{"id":"https://openalex.org/keywords/pharmacophore-based-drug-design","display_name":"pharmacophore-based drug design","score":0.8379999995231628},{"id":"https://openalex.org/keywords/electronic-effects","display_name":"electronic effects","score":0.9490000009536743},{"id":"https://openalex.org/keywords/castration-resistant-prostate-cancer","display_name":"castration-resistant prostate cancer","score":0.8379999995231628},{"id":"https://openalex.org/keywords/androgen-deprivation-therapy","display_name":"androgen deprivation therapy","score":0.8569999933242798},{"id":"https://openalex.org/keywords/enzalutamide","display_name":"enzalutamide","score":0.843999981880188},{"id":"https://openalex.org/keywords/lncap-cells","display_name":"LNCaP cells","score":0.9419999718666077},{"id":"https://openalex.org/keywords/amide-groups","display_name":"amide groups","score":0.5849999785423279},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.43799999356269836}],"concepts":[{"id":"https://openalex.org/C56173144","wikidata":"https://www.wikidata.org/wiki/Q1539893","display_name":"Pharmacophore","level":2,"score":0.9142240881919861},{"id":"https://openalex.org/C2776551883","wikidata":"https://www.wikidata.org/wiki/Q1996756","display_name":"Enzalutamide","level":5,"score":0.8913319110870361},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.745703399181366},{"id":"https://openalex.org/C61367390","wikidata":"https://www.wikidata.org/wiki/Q416601","display_name":"Androgen receptor","level":4,"score":0.7047220468521118},{"id":"https://openalex.org/C2779723316","wikidata":"https://www.wikidata.org/wiki/Q6459234","display_name":"LNCaP","level":4,"score":0.6554355025291443},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5916759967803955},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5391000509262085},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.4999043941497803},{"id":"https://openalex.org/C2910322876","wikidata":"https://www.wikidata.org/wiki/Q574820","display_name":"Androgen Receptor Antagonists","level":5,"score":0.4574136435985565},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.36244696378707886},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3317475914955139},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3086123466491699},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.30716437101364136},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21645715832710266},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.19018453359603882}],"mesh":[{"descriptor_ui":"D000092165","descriptor_name":"Pharmacophore","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000726","descriptor_name":"Androgen Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000728","descriptor_name":"Androgens","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000728","descriptor_name":"Androgens","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000728","descriptor_name":"Androgens","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010669","descriptor_name":"Phenylthiohydantoin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011944","descriptor_name":"Receptors, Androgen","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059002","descriptor_name":"Androgen Receptor Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D059002","descriptor_name":"Androgen Receptor Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D064129","descriptor_name":"Prostatic Neoplasms, Castration-Resistant","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1111/cbdd.14151","doi":"https://doi.org/10.1111/cbdd.14151","is_oa":false,"landing_page_url":"https://doi.org/10.1111/cbdd.14151","pdf_url":null,"source":{"id":"https://openalex.org/S123587420","display_name":"Chemical Biology & Drug Design","issn_l":"1747-0277","issn":["1747-0277","1747-0285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chemical Biology & Drug Design","raw_type":"journal-article"},{"id":"pmid:36198102","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36198102","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chemical biology & drug design","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W155356103","https://openalex.org/W2006138763","https://openalex.org/W2009423060","https://openalex.org/W2016650790","https://openalex.org/W2022635468","https://openalex.org/W2031168104","https://openalex.org/W2043729296","https://openalex.org/W2051025382","https://openalex.org/W2054881399","https://openalex.org/W2054975178","https://openalex.org/W2066570340","https://openalex.org/W2070624290","https://openalex.org/W2079700809","https://openalex.org/W2081365151","https://openalex.org/W2085612296","https://openalex.org/W2117325725","https://openalex.org/W2124994599","https://openalex.org/W2130189600","https://openalex.org/W2155368234","https://openalex.org/W2170552969","https://openalex.org/W2175730666","https://openalex.org/W2176061850","https://openalex.org/W2261870911","https://openalex.org/W2330799739","https://openalex.org/W2481479138","https://openalex.org/W2626230492","https://openalex.org/W2746932121","https://openalex.org/W2807985734","https://openalex.org/W2889646458","https://openalex.org/W2911188335","https://openalex.org/W2911362138","https://openalex.org/W2943609335","https://openalex.org/W2968207372","https://openalex.org/W3112701574","https://openalex.org/W3142498305","https://openalex.org/W3166214635","https://openalex.org/W3198382015","https://openalex.org/W3212784804","https://openalex.org/W4211196614"],"related_works":["https://openalex.org/W3198382015","https://openalex.org/W4297242774","https://openalex.org/W2152046394","https://openalex.org/W3092053127","https://openalex.org/W2914185679","https://openalex.org/W2923738233","https://openalex.org/W608773482","https://openalex.org/W2889244985","https://openalex.org/W2029754338","https://openalex.org/W2891714822"],"abstract_inverted_index":{"Abstract":[0],"Because":[1],"androgen":[2,32],"receptor":[3],"(AR)":[4],"signalling":[5,63],"is":[6,127,143,162],"important":[7],"for":[8,166],"the":[9,45,97,108,130,137,146,151,155,158,178,195],"development":[10,46],"and":[11,27,86,105,111,148],"progression":[12],"of":[13,39,47,76,100,150,172,191,197],"prostate":[14,52],"cancer":[15,53],"(PC),":[16],"AR":[17,40,62,81,168],"antagonists":[18,41,82],"are":[19,28],"utilized":[20],"in":[21,44,103,125],"clinical":[22],"practices":[23],"to":[24,30,65,68,95,135],"treat":[25],"PC":[26,90],"referred":[29],"as":[31,50,182],"deprivation":[33],"therapy":[34],"(ADT).":[35],"However,":[36],"continued":[37],"administration":[38],"often":[42],"results":[43],"resistance,":[48],"known":[49],"castration\u2010resistant":[51],"(CRPC).":[54],"Despite":[55,154],"castration,":[56],"it":[57],"has":[58,177],"been":[59],"demonstrated":[60],"that":[61,157],"continues":[64],"be":[66],"fundamental":[67],"tumour":[69],"growth.":[70],"In":[71,118,133],"this":[72,170],"regard,":[73],"a":[74,163],"series":[75,196],"readily":[77],"synthesizable":[78],"4,4\u2010dimethylimidazolidine\u20102\u2010one":[79],"pharmacophore\u2010based":[80],"(FAR01\u2010FAR11)":[83],"were":[84],"designed":[85],"synthesized.":[87],"Androgen\u2010dependent":[88],"LNCaP":[89],"cell":[91],"line":[92],"was":[93],"used":[94],"test":[96],"AR\u2010antagonist":[98],"activity":[99,181],"these":[101],"compounds":[102],"vitro":[104],"compared":[106],"with":[107,187],"U.S.":[109],"Food":[110],"Drug":[112],"Administration":[113],"(FDA)":[114],"approved":[115],"second\u2010generation":[116],"enzalutamide.":[117],"our":[119],"previous":[120],"work,":[121],"rigid":[122],"thiohydantoin":[123],"pharmacophore":[124,147],"enzalutamide":[126,183],"replaced":[128],"by":[129],"flexible":[131],"4,4\u2010dimethylimidazolidin\u20102\u2010one.":[132],"order":[134],"improve":[136],"flexibility":[138],"further,":[139],"one":[140,149],"methylene":[141],"group":[142,161],"introduced":[144],"between":[145],"aromatic":[152],"ring.":[153],"fact":[156],"amide":[159],"functional":[160],"crucial":[164],"characteristic":[165],"building":[167],"antagonists,":[169],"class":[171],"molecules":[173],"lacks":[174],"one.":[175],"FAR06":[176],"exact":[179],"same":[180],"(IC50:":[184],"0.782":[185],"\u03bcM)":[186],"an":[188],"IC50":[189],"value":[190],"0.801":[192],"\u03bcM":[193],"among":[194],"compounds.":[198]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-10-06T00:00:00"}